Trials / Active Not Recruiting
Active Not RecruitingNCT04867525
Registry Platform Colorectal Cancer
Clinical Research Platform for Molecular Testing, Treatment, Quality of Life and Outcome of Patients With Metastatic Colorectal Cancer Receiving Systemic Therapy (AZURITE)
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- iOMEDICO AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic colorectal cancer, treated in palliative intention in daily routine practice in Germany.
Detailed description
AZURITE is a national, observational, prospective, longitudinal, multicenter cohort study (tumor registry platform) with the purpose to record information on the antineoplastic treatment of metastatic colorectal cancer in Germany. The registry will follow patients for up to three years. It will identify common therapeutic sequences and changes in the treatment of the disease. At inclusion, data in patient characteristics, comorbidities, tumor characteristics and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Health-related quality of life (HRQoL) will be evaluated for up to three years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Physician's choice according to patient's needs. | Routine care as per site standard. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2022-04-04
- Completion
- 2026-04-01
- First posted
- 2021-04-30
- Last updated
- 2025-05-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04867525. Inclusion in this directory is not an endorsement.